Mydacla contains Drug / Molecule called “Daclatasvir”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV).It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.
Mydacla is used for treatment of patients with chronic Hepatitis C.
- Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate.
- Mydacla should not be used during pregnancy or in women of childbearing potential not using contraception.
60 mg Tablets.
1* 28 Tablets (Bottle)
Store at room temperature (25°C), protected from sunlight.